High Crystallinity Alpha-1,3-Glucan Particle Control

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing forms of insoluble alpha-1,3-glucan lack high crystallinity and controlled particle size, which limits their economic value and performance in various applications.

Innovation Solution

Development of insoluble alpha-1,3-glucan particles with a degree of crystallinity of at least 0.65, a weight-average degree of polymerization (DPw) of at least 15, and at least 50% alpha-1,3 glycosidic linkages, with a significant portion of particles being in plate form and having controlled diameters.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Stability of the object's composition

If conventional enzymatic synthesis methods are used to produce insoluble alpha-1,3-glucan, then the glucan can be prepared with alpha-1,3 glycosidic linkages, but the degree of crystallinity remains low and particle size is uncontrolled

Engineering Contradiction:
Improvedegree of crystallinityVSAvoidparticle size control
Core Design Contradiction:
Stability of the object's compositionVSManufacturing precision

Solution Approach 1:

The patent applies parameter changes by controlling the degree of polymerization (DP) within specific ranges (DP 15-100 for high crystallinity, DP 35-100 for controlled particle size) and adjusting alpha-1,3 linkage content (at least 50%) to achieve the desired balance between crystallinity and particle size characteristics

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent implements local quality by creating specific structural characteristics within the glucan particles, including plate-form morphology with controlled diameter distributions (e.g., at least 70% of particles with diameter less than 1.0 micron, or 45-55% with diameter less than 0.35 micron), and high crystallinity regions that provide enhanced performance in specific applications

Inventive Principle:
Principle #3Local quality

2Reliability

If high crystallinity is achieved in insoluble alpha-1,3-glucan particles, then economic value and performance characteristics are enhanced, but the complexity of production process increases

Engineering Contradiction:
Improveperformance characteristicsVSAvoidproduction process complexity
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The patent applies preliminary action by pre-establishing the correct degree of polymerization (DP 15-100) and alpha-1,3 linkage content (at least 50%) during the enzymatic synthesis stage, which enables the glucan to spontaneously form high crystallinity structures without requiring additional complex post-processing steps

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The patent utilizes parameter changes by optimizing the enzymatic reaction conditions to produce glucan with specific molecular weight characteristics (DP 15-100) and linkage composition (at least 50% alpha-1,3), which directly results in high crystallinity and controlled particle size, thereby achieving enhanced performance without significantly increasing process complexity

Inventive Principle:
Principle #35Parameter changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The resulting insoluble alpha-1,3-glucan particles exhibit enhanced economic value and performance characteristics, including stability under low pH conditions, unique optical characteristics, improved viscosity profiles, and enhanced pigment extender function in paint.

Implementation Method 1

providing insoluble alpha-glucan as produced in an enzymatic reaction comprising at least water, sucrose and a glucosyltransferase enzyme that synthesizes the insoluble alpha-glucan

Methodology Applied
Scientific EffectEnzymatic reaction: Enzyme

Implementation Method 2

hydrolyzing the insoluble alpha-glucan to insoluble alpha-glucan particles with a DPw of about 35 to about 100, wherein the hydrolyzing is performed under aqueous conditions at a pH of 2.0 or less

Methodology Applied
Scientific EffectHydrolysis: Hydrolysis

Data Source

PatentUS12319753B2Highly crystalline alpha-1,3-glucan
Publication Date: 2025.06.03 NUTRITION & BIOSCIENCES USA 4 INC
  • US12319753B2 patent drawing
  • US12319753B2 patent drawing
  • US12319753B2 patent drawing

AI summary

Disclosed herein are compositions comprising insoluble alpha-glucan particles having a high degree of crystallinity and small particle size. For example, the alpha-glucan particles can have a degree of crystallinity of at least about 0.65, and/or an average size of less than a micron. At least 50% of the glycosidic linkages of the insoluble alpha-glucan in the disclosed particles are alpha-1,3 glycosidic linkages. Further disclosed are methods of producing insoluble alpha-glucan particles, as well as their use in various applications and products.